Translational Approach for Predicting Human Pharmacokinetics of Engineered Therapeutic Monoclonal Antibodies with Increased FcRn-Binding Mutations

被引：0
|
作者：
Kenta Haraya
Tatsuhiko Tachibana
机构：
[1] Chugai Pharmaceutical Co.,
[2] Ltd.,undefined
来源：
BioDrugs | 2023年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：99 / 108
页数：9
相关论文
共 25 条
  • [21] Predicting therapeutic monoclonal antibody efficacious human doses from mouse experimental tumors: a pharmacokinetic/pharmacodynamic approach
    Zheng, Songmao
    Zhou, Honghui
    Wang, Weirong
    CANCER RESEARCH, 2015, 75
  • [22] Novel anti-Trop-2 monoclonal antibodies with unique binding specificities show therapeutic synergy against most human cancers
    Guerra, Emanuela
    Trerotola, Marco
    Relli, Valeria
    Pedicone, Chiara
    Amore, Antonella D'
    Dini, Francesca
    Fratarcangeli, Silvia
    Alberti, Saverio
    CANCER RESEARCH, 2017, 77
  • [23] HUMAN-ENGINEERED MONOCLONAL-ANTIBODIES RETAIN FULL SPECIFIC BINDING-ACTIVITY BY PRESERVING NON-CDR COMPLEMENTARITY-MODULATING RESIDUES
    STUDNICKA, GM
    SOARES, S
    BETTER, M
    WILLIAMS, RE
    NADELL, R
    HORWITZ, AH
    PROTEIN ENGINEERING, 1994, 7 (06): : 805 - 814
  • [24] Methods to measure the binding of therapeutic monoclonal antibodies to the human Fc receptor FcγRIII (CD16) using real time kinetic analysis and flow cytometry
    Harrison, Alice
    Liu, Zhe
    Makweche, Schona
    Maskell, Kevin
    Qi, Hong
    Hale, Geoff
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 63 : 23 - 28
  • [25] A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site
    Li, Liuzhe
    Wang, Xiao-Hong
    Williams, Constance
    Volsky, Barbara
    Steczko, Olivia
    Seaman, Michael S.
    Luthra, Kalpana
    Nyambi, Phillipe
    Nadas, Arthur
    Giudicelli, Veronique
    Lefranc, Marie-Paule
    Zolla-Pazner, Susan
    Gorny, Miroslaw K.
    MOLECULAR IMMUNOLOGY, 2015, 66 (02) : 364 - 374
123